首站-论文投稿智能助手
典型文献
Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs
文献摘要:
The ongoing COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)with a positive-stranded RNA genome.Current proteomic studies of SARS-CoV-2 mainly focus on the proteins encoded by its genomic RNA(gRNA)or canonical subgenomic RNAs(sgRNAs).Here,we systematically inves-tigated the translation landscape of SARS-CoV-2,especially its noncanonical sgRNAs.We first constructed a strict pipeline,named vipep,for identifying reliable peptides derived from RNA viruses using RNA-seq and mass spectrometry data.We applied vipep to analyze 24 sets of mass spectrometry data related to SARS-CoV-2 infection.In addition to known canonical proteins,we identified many noncanonical sgRNA-derived peptides,which stably increase after viral infection.Furthermore,we explored the potential functions of those proteins encoded by noncanonical sgRNAs and found that they can bind to viral RNAs and may have immunogenic ac-tivity.The generalized vipep pipeline is applicable to any RNA viruses and these results have expanded the SARS-CoV-2 translation map,providing new insights for understanding the functions of SARS-CoV-2 sgRNAs.
文献关键词:
作者姓名:
Kai Wu;Dehe Wang;Junhao Wang;Yu Zhou
作者机构:
State Key Laboratory of Virology,College of Life Sciences,Wuhan University,Wuhan,430072,China;TaiKang Center for Life and Medical Sciences,RNA Institute,Wuhan University,Wuhan,430072,China;Institute for Advanced Studies,Wuhan University,Wuhan,430072,China;Frontier Science Center for Immunology and Metabolism,Wuhan University,Wuhan,430072,China
文献出处:
引用格式:
[1]Kai Wu;Dehe Wang;Junhao Wang;Yu Zhou-.Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs)[J].中国病毒学,2022(06):813-822
A类:
subgenomic,vipep
B类:
Translation,landscape,SARS,CoV,noncanonical,ongoing,pandemic,is,caused,by,severe,acute,respiratory,syndrome,coronavirus,positive,stranded,genome,Current,proteomic,studies,mainly,focus,proteins,encoded,its,sgRNAs,Here,we,systematically,inves,tigated,translation,especially,We,first,constructed,strict,pipeline,named,identifying,reliable,peptides,derived,from,viruses,using,seq,mass,spectrometry,data,applied,analyze,sets,related,infection,In,addition,known,identified,many,which,stably,increase,after,viral,Furthermore,explored,potential,functions,those,found,that,they,bind,may,have,immunogenic,tivity,generalized,applicable,these,results,expanded,map,providing,new,insights,understanding
AB值:
0.521543
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation
Yichen Li;Shuaiyao Lu;Jinge Gu;Wencheng Xia;Shengnan Zhang;Shenqing Zhang;Yan Wang;Chong Zhang;Yunpeng Sun;Jian Lei;Cong Liu;Zhaoming Su;Juntao Yang;Xiaozhong Peng;Dan Li-Bio-X Institutes,Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders,Ministry of Education,Shanghai Jiao Tong University,Shanghai 200030,China;School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200030,China;National Kunming High-level Biosafety Primate Research Center,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650031,China;State Key Laboratory of Medical Molecular Biology,Chinese Academy of Medical Sciences,School of Basic Medicine,Peking Union Medical College,Beijing 100005,China;Interdisciplinary Research Center on Biology and Chemistry,Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences,Shanghai 201210,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Biotherapy,Department of Geriatrics and National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu 610041,China;State Key Laboratory of Medical Molecular Biology,Department of Biochemistry and Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Bio-X-Renji Hospital Research Center,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200240,China;Zhangjiang Institute for Advanced Study,Shanghai Jiao Tong University,Shanghai 200240,China
Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
Shaojun Zhang;Wenze Huang;Lili Ren;Xiaohui Ju;Mingli Gong;Jian Rao;Lei Sun;Pan Li;Qiang Ding;Jianwei Wang;Qiangfeng Cliff Zhang-MOE Key Laboratory of Bioinformatics,Beijing Advanced Innovation Center for Structural Biology & Frontier Research Center for Biological Structure,Center for Synthetic and Systems Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory,Institute of Pathogen Biology,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China;Key Laboratory of Respiratory Disease Pathogenomics,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;Center for infectious Disease Research,School of Medicine,Tsinghua University,Beijing,China
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma;Xinghai Zhang;Peiyi Zheng;Peter H.Dube;Weihong Zeng;Shaohong Chen;Qingyu Cheng;Yunru Yang;Yan Wu;Junhui Zhou;Xiaowen Hu;Yan Xiang;Huajun Zhang;Sandra Chiu;Tengchuan Jin-Department of Pulmonary and Critical Care Medicine,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;Laboratory of Structural Immunology,CAS Key Laboratory of Innate Immunity and Chronic Disease,Hefei National Laboratory for Physical Sciences at Microscale,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;Department of Microbiology,Immunology and Molecular Genetics,University of Texas Health Science Center at San Antonio,San Antonio,TX,USA;University of Chinese Academy of Sciences,Beijing,China;Institute of Health and Medicine,Hefei Comprehensive National Science Center,Hefei,Anhui,China
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yang Yi;Meng Zhang;Heng Xue;Rong Yu;Yang-Oujie Bao;Yi Kuang;Yue Chai;Wen Ma;Jing Wang;Xiaomeng Shi;Wenzhe Li;Wei Hong;Junhua Li;Elishiba Muturi;Hongping Wei;Joachim Wlodarz;Szczepan Roszak;Xue Qiao;Hang Yang;Min Ye-State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;CAS Key Laboratory of Special Pathogens and Biosafety,Center for Biosafety Mega-Science,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan 430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Faculty of Science and Technology,University of Silesia,Katowice 40-007,Poland;Department of Physical and Quantum Chemistry,Faculty of Chemistry,Wroclaw University of Science and Technology,Wroclaw 50-370,Poland
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Peng-xuan Ren;Wei-juan Shang;Wan-chao Yin;Huan Ge;Lin Wang;Xiang-lei Zhang;Bing-qian Li;Hong-lin Li;Ye-chun Xu;Eric H.Xu;Hua-liang Jiang;Li-li Zhu;Lei-ke Zhang;Fang Bai-School of Life Science and Technology,and Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China;Department of Chemistry,Imperial College London,London,United Kingdom;University of Chinese Academy of Sciences,Beijing 100049,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。